MedTrace Logo

Effects of Pulsed Electromagnetic Field Therapy on Sport Performance and Recovery

NCT07288892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-08

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if pulsed electromagnetic field (PEMF) therapy works to improve sports performance and recovery in athletes. The main questions it aims to answer are:

* Does PEMF therapy enhance participants' performance during exercise?
* Does PEMF therapy enhance recovery in participants after exercise? Researchers will compare active PEMF therapy to sham PEMF therapy (using the same device for both, but without any electromagnetic fields) to see if active PEMF therapy is effective in improving sports performance and recovery.

Participants will:

* Receive active pulsed electromagnetic field therapy or sham pulsed electromagnetic field therapy twice a week for 8 weeks.
* Visit the laboratory at baseline, 8 weeks, and 12 weeks for sports performance and recovery assessments.

Conditions

  • Sport Performance
  • Sport Recovery
  • Athlete

Interventions

DEVICE

Active Pulsed Electromagnetic Field Therapy

The experimental group will receive active Pulsed Electromagnetic Field (PEMF) therapy twice weekly for 8 weeks, for a total of 16 sessions. Participants will sit comfortably in a chair with their legs placed inside the solenoid of the PEMF device. The active PEMF settings are 1.2 milliTesla (mT) at 50 Hertz (Hz). Each PEMF session will last 20 minutes, with 10 minutes of active PEMF exposure per leg.

DEVICE

Sham Pulsed Electromagnetic Field Therapy

The control group will receive sham Pulsed Electromagnetic Field (PEMF) therapy twice weekly for 8 weeks, for a total of 16 sessions. Participants will sit comfortably in a chair with their legs placed inside the solenoid of the PEMF device. The sham PEMF settings are 0 milliTesla (mT) at 0 Hertz (Hz). Each PEMF session will last 20 minutes, with 10 minutes of sham PEMF exposure per leg.

Sponsors & Collaborators

  • QuantumTX Pte Ltd

    collaborator NETWORK

  • Nanyang Technological University

    lead OTHER

Principal Investigators

  • Pui Wah KONG, PhD · Nanyang Technological University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-19
Primary Completion
2026-06-30
Completion
2026-08-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07288892 on ClinicalTrials.gov